Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Vagus nerve stimulation for seizures.

B M Uthman1

  • 1Department of Neurology and Neuroscience, University of Florida, and College of Medicine and Malcolm Randall Veterans Administration Medical Center (VAMC), Gainesville, FL, USA. basim.uthman@med.va.gov

Archives of Medical Research
|October 19, 2000
PubMed
Summary

Vagus nerve stimulation (VNS) offers a well-tolerated adjunctive therapy for intractable epilepsy, significantly reducing partial onset seizures. This treatment is a viable alternative for patients unsuitable for surgery or seeking better seizure control.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

New onset geriatric epilepsy: a randomized study of gabapentin, lamotrigine, and carbamazepine.

Neurology·2005
Same author

Safety and efficacy of two pregabalin regimens for add-on treatment of partial epilepsy.

Neurology·2005
Same author

Effectiveness of vagus nerve stimulation in epilepsy patients: a 12-year observation.

Neurology·2004
Same author

Phenytoin penetration into brain after administration of phenytoin or fosphenytoin.

Epilepsia·1999
Same author

A comparison of four treatments for generalized convulsive status epilepticus. Veterans Affairs Status Epilepticus Cooperative Study Group.

The New England journal of medicine·1998
Same author

Vagus nerve stimulation therapy for partial-onset seizures: a randomized active-control trial.

Neurology·1998

Area of Science:

  • Neurology
  • Neurosurgery
  • Medical Devices

Background:

  • Epilepsy affects 1% of the population, with nearly 30% experiencing intractable seizures resistant to medication.
  • Existing treatments, including new drugs and epilepsy surgery, have limitations in efficacy, side effect profiles, and patient candidacy.
  • Vagus nerve stimulation (VNS) presents a novel adjunctive therapy for managing intractable epilepsy.

Purpose of the Study:

  • To evaluate the efficacy and safety of Vagus Nerve Stimulation (VNS) as an adjunctive therapy for intractable epilepsy.
  • To assess VNS as an alternative for patients with partial onset seizures who are not candidates for or have failed other treatments.

Main Methods:

  • VNS involves surgically implanting a generator connected to the vagus nerve, delivering intermittent electrical stimuli.

Related Experiment Videos

  • Initial feasibility and safety were established in pilot studies, followed by multicenter, double-blind protocols.
  • Patient outcomes, including seizure frequency, intensity, and adverse events, were monitored over time.

    • Main Results:

    • VNS demonstrated a statistically significant reduction in partial onset seizures.
    • Adverse events were generally mild and transient, including voice alteration and throat sensations.
    • Long-term follow-up indicated sustained seizure frequency and intensity reduction.

    Conclusions:

    • Vagus nerve stimulation (VNS) is an effective and well-tolerated adjunctive therapy for intractable epilepsy.
    • VNS offers a less invasive option compared to epilepsy surgery and a better side effect profile than some medications.
    • While not a replacement for epilepsy surgery in select patients, VNS provides a valuable treatment option for a broader patient group.